WO2007091827A1 - Extract from submerged culture of fomitopsis pinicola mycelia and hypoglycemic composition comprising the same - Google Patents
Extract from submerged culture of fomitopsis pinicola mycelia and hypoglycemic composition comprising the same Download PDFInfo
- Publication number
- WO2007091827A1 WO2007091827A1 PCT/KR2007/000646 KR2007000646W WO2007091827A1 WO 2007091827 A1 WO2007091827 A1 WO 2007091827A1 KR 2007000646 W KR2007000646 W KR 2007000646W WO 2007091827 A1 WO2007091827 A1 WO 2007091827A1
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- extract
- medium
- green tea
- fomitopsis pinicola
- citrus peel
- Prior art date
Links
- 239000000284 extract Substances 0.000 title claims abstract description 77
- 241000123150 Fomitopsis pinicola Species 0.000 title claims abstract description 54
- 239000000203 mixture Substances 0.000 title claims abstract description 20
- 230000002218 hypoglycaemic effect Effects 0.000 title claims description 17
- 241000207199 Citrus Species 0.000 claims abstract description 39
- 235000020971 citrus fruits Nutrition 0.000 claims abstract description 39
- 244000269722 Thea sinensis Species 0.000 claims abstract description 29
- 235000009569 green tea Nutrition 0.000 claims abstract description 29
- 239000008103 glucose Substances 0.000 claims abstract description 23
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 claims abstract description 21
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 43
- 235000013399 edible fruits Nutrition 0.000 claims description 20
- 239000012153 distilled water Substances 0.000 claims description 11
- 238000001816 cooling Methods 0.000 claims description 10
- 239000000843 powder Substances 0.000 claims description 10
- 229940041514 candida albicans extract Drugs 0.000 claims description 7
- 238000000605 extraction Methods 0.000 claims description 7
- 229940094952 green tea extract Drugs 0.000 claims description 7
- 235000020688 green tea extract Nutrition 0.000 claims description 7
- 239000012138 yeast extract Substances 0.000 claims description 7
- 239000001888 Peptone Substances 0.000 claims description 6
- 108010080698 Peptones Proteins 0.000 claims description 6
- 235000019319 peptone Nutrition 0.000 claims description 6
- 238000010438 heat treatment Methods 0.000 claims description 5
- 238000001914 filtration Methods 0.000 claims 2
- 239000008213 purified water Substances 0.000 claims 2
- 238000010298 pulverizing process Methods 0.000 claims 1
- 206010012601 diabetes mellitus Diseases 0.000 abstract description 36
- 210000004369 blood Anatomy 0.000 abstract description 29
- 239000008280 blood Substances 0.000 abstract description 29
- 230000000694 effects Effects 0.000 abstract description 29
- 230000003178 anti-diabetic effect Effects 0.000 abstract description 12
- 235000013305 food Nutrition 0.000 abstract description 6
- 239000003472 antidiabetic agent Substances 0.000 abstract description 3
- 239000002609 medium Substances 0.000 description 45
- 241000700159 Rattus Species 0.000 description 17
- 239000000243 solution Substances 0.000 description 17
- 244000061456 Solanum tuberosum Species 0.000 description 15
- 235000002595 Solanum tuberosum Nutrition 0.000 description 15
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 13
- 239000012141 concentrate Substances 0.000 description 13
- 239000013256 coordination polymer Substances 0.000 description 12
- 235000005911 diet Nutrition 0.000 description 12
- 230000037213 diet Effects 0.000 description 11
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 10
- NOESYZHRGYRDHS-UHFFFAOYSA-N insulin Chemical compound N1C(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(NC(=O)CN)C(C)CC)CSSCC(C(NC(CO)C(=O)NC(CC(C)C)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CCC(N)=O)C(=O)NC(CC(C)C)C(=O)NC(CCC(O)=O)C(=O)NC(CC(N)=O)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CSSCC(NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2C=CC(O)=CC=2)NC(=O)C(CC(C)C)NC(=O)C(C)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2NC=NC=2)NC(=O)C(CO)NC(=O)CNC2=O)C(=O)NCC(=O)NC(CCC(O)=O)C(=O)NC(CCCNC(N)=N)C(=O)NCC(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC(O)=CC=3)C(=O)NC(C(C)O)C(=O)N3C(CCC3)C(=O)NC(CCCCN)C(=O)NC(C)C(O)=O)C(=O)NC(CC(N)=O)C(O)=O)=O)NC(=O)C(C(C)CC)NC(=O)C(CO)NC(=O)C(C(C)O)NC(=O)C1CSSCC2NC(=O)C(CC(C)C)NC(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CC(N)=O)NC(=O)C(NC(=O)C(N)CC=1C=CC=CC=1)C(C)C)CC1=CN=CN1 NOESYZHRGYRDHS-UHFFFAOYSA-N 0.000 description 10
- 235000000346 sugar Nutrition 0.000 description 10
- 235000001674 Agaricus brunnescens Nutrition 0.000 description 9
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 9
- 150000004676 glycans Chemical class 0.000 description 9
- 210000004185 liver Anatomy 0.000 description 9
- 229920001282 polysaccharide Polymers 0.000 description 9
- 239000005017 polysaccharide Substances 0.000 description 9
- 238000002835 absorbance Methods 0.000 description 8
- 238000000034 method Methods 0.000 description 8
- 235000018823 dietary intake Nutrition 0.000 description 7
- 150000002632 lipids Chemical class 0.000 description 7
- ZSJLQEPLLKMAKR-GKHCUFPYSA-N streptozocin Chemical compound O=NN(C)C(=O)N[C@H]1[C@@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O ZSJLQEPLLKMAKR-GKHCUFPYSA-N 0.000 description 7
- 230000006698 induction Effects 0.000 description 6
- UFTFJSFQGQCHQW-UHFFFAOYSA-N triformin Chemical compound O=COCC(OC=O)COC=O UFTFJSFQGQCHQW-UHFFFAOYSA-N 0.000 description 6
- 235000019786 weight gain Nutrition 0.000 description 6
- 230000004584 weight gain Effects 0.000 description 6
- 102000004877 Insulin Human genes 0.000 description 5
- 108090001061 Insulin Proteins 0.000 description 5
- 238000012258 culturing Methods 0.000 description 5
- 230000002440 hepatic effect Effects 0.000 description 5
- 229940125396 insulin Drugs 0.000 description 5
- 238000002360 preparation method Methods 0.000 description 5
- LRFVTYWOQMYALW-UHFFFAOYSA-N 9H-xanthine Chemical compound O=C1NC(=O)NC2=C1NC=N2 LRFVTYWOQMYALW-UHFFFAOYSA-N 0.000 description 4
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 4
- 102000004190 Enzymes Human genes 0.000 description 4
- 108090000790 Enzymes Proteins 0.000 description 4
- 108010023302 HDL Cholesterol Proteins 0.000 description 4
- 108010093894 Xanthine oxidase Proteins 0.000 description 4
- 102100033220 Xanthine oxidase Human genes 0.000 description 4
- 230000037396 body weight Effects 0.000 description 4
- 235000012000 cholesterol Nutrition 0.000 description 4
- 239000004615 ingredient Substances 0.000 description 4
- 210000003734 kidney Anatomy 0.000 description 4
- 210000002966 serum Anatomy 0.000 description 4
- 208000001072 type 2 diabetes mellitus Diseases 0.000 description 4
- 229940088594 vitamin Drugs 0.000 description 4
- 229930003231 vitamin Natural products 0.000 description 4
- 235000013343 vitamin Nutrition 0.000 description 4
- 239000011782 vitamin Substances 0.000 description 4
- 208000024172 Cardiovascular disease Diseases 0.000 description 3
- 238000008214 LDL Cholesterol Methods 0.000 description 3
- 240000000599 Lentinula edodes Species 0.000 description 3
- 235000001715 Lentinula edodes Nutrition 0.000 description 3
- 241001465754 Metazoa Species 0.000 description 3
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 3
- 239000011149 active material Substances 0.000 description 3
- 230000001093 anti-cancer Effects 0.000 description 3
- 230000003064 anti-oxidating effect Effects 0.000 description 3
- 230000003247 decreasing effect Effects 0.000 description 3
- 230000001419 dependent effect Effects 0.000 description 3
- 239000003814 drug Substances 0.000 description 3
- 239000001963 growth medium Substances 0.000 description 3
- 239000000463 material Substances 0.000 description 3
- VLKZOEOYAKHREP-UHFFFAOYSA-N n-Hexane Chemical compound CCCCCC VLKZOEOYAKHREP-UHFFFAOYSA-N 0.000 description 3
- 235000015097 nutrients Nutrition 0.000 description 3
- NLKNQRATVPKPDG-UHFFFAOYSA-M potassium iodide Chemical compound [K+].[I-] NLKNQRATVPKPDG-UHFFFAOYSA-M 0.000 description 3
- 239000002244 precipitate Substances 0.000 description 3
- 238000012360 testing method Methods 0.000 description 3
- 210000002700 urine Anatomy 0.000 description 3
- 210000003462 vein Anatomy 0.000 description 3
- YBJHBAHKTGYVGT-ZKWXMUAHSA-N (+)-Biotin Chemical compound N1C(=O)N[C@@H]2[C@H](CCCCC(=O)O)SC[C@@H]21 YBJHBAHKTGYVGT-ZKWXMUAHSA-N 0.000 description 2
- GVJHHUAWPYXKBD-UHFFFAOYSA-N (±)-α-Tocopherol Chemical compound OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 description 2
- FPIPGXGPPPQFEQ-UHFFFAOYSA-N 13-cis retinol Natural products OCC=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-UHFFFAOYSA-N 0.000 description 2
- VZSRBBMJRBPUNF-UHFFFAOYSA-N 2-(2,3-dihydro-1H-inden-2-ylamino)-N-[3-oxo-3-(2,4,6,7-tetrahydrotriazolo[4,5-c]pyridin-5-yl)propyl]pyrimidine-5-carboxamide Chemical compound C1C(CC2=CC=CC=C12)NC1=NC=C(C=N1)C(=O)NCCC(N1CC2=C(CC1)NN=N2)=O VZSRBBMJRBPUNF-UHFFFAOYSA-N 0.000 description 2
- 229920001817 Agar Polymers 0.000 description 2
- 244000251953 Agaricus brunnescens Species 0.000 description 2
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 2
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 2
- 244000201986 Cassia tora Species 0.000 description 2
- 235000014552 Cassia tora Nutrition 0.000 description 2
- 229920002261 Corn starch Polymers 0.000 description 2
- 229920001503 Glucan Polymers 0.000 description 2
- 108010010234 HDL Lipoproteins Proteins 0.000 description 2
- 206010019842 Hepatomegaly Diseases 0.000 description 2
- 206010020772 Hypertension Diseases 0.000 description 2
- 206010022489 Insulin Resistance Diseases 0.000 description 2
- 108010028554 LDL Cholesterol Proteins 0.000 description 2
- PVNIIMVLHYAWGP-UHFFFAOYSA-N Niacin Chemical compound OC(=O)C1=CC=CN=C1 PVNIIMVLHYAWGP-UHFFFAOYSA-N 0.000 description 2
- AUNGANRZJHBGPY-SCRDCRAPSA-N Riboflavin Chemical compound OC[C@@H](O)[C@@H](O)[C@@H](O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-SCRDCRAPSA-N 0.000 description 2
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 2
- ZSJLQEPLLKMAKR-UHFFFAOYSA-N Streptozotocin Natural products O=NN(C)C(=O)NC1C(O)OC(CO)C(O)C1O ZSJLQEPLLKMAKR-UHFFFAOYSA-N 0.000 description 2
- 208000006011 Stroke Diseases 0.000 description 2
- 241000222355 Trametes versicolor Species 0.000 description 2
- LEHOTFFKMJEONL-UHFFFAOYSA-N Uric Acid Chemical compound N1C(=O)NC(=O)C2=C1NC(=O)N2 LEHOTFFKMJEONL-UHFFFAOYSA-N 0.000 description 2
- TVWHNULVHGKJHS-UHFFFAOYSA-N Uric acid Natural products N1C(=O)NC(=O)C2NC(=O)NC21 TVWHNULVHGKJHS-UHFFFAOYSA-N 0.000 description 2
- FPIPGXGPPPQFEQ-BOOMUCAASA-N Vitamin A Natural products OC/C=C(/C)\C=C\C=C(\C)/C=C/C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-BOOMUCAASA-N 0.000 description 2
- 230000005856 abnormality Effects 0.000 description 2
- ZSLZBFCDCINBPY-ZSJPKINUSA-N acetyl-CoA Chemical compound O[C@@H]1[C@H](OP(O)(O)=O)[C@@H](COP(O)(=O)OP(O)(=O)OCC(C)(C)[C@@H](O)C(=O)NCCC(=O)NCCSC(=O)C)O[C@H]1N1C2=NC=NC(N)=C2N=C1 ZSLZBFCDCINBPY-ZSJPKINUSA-N 0.000 description 2
- 230000001154 acute effect Effects 0.000 description 2
- 239000008272 agar Substances 0.000 description 2
- FPIPGXGPPPQFEQ-OVSJKPMPSA-N all-trans-retinol Chemical compound OC\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-OVSJKPMPSA-N 0.000 description 2
- 150000001413 amino acids Chemical class 0.000 description 2
- 238000004458 analytical method Methods 0.000 description 2
- 210000000709 aorta Anatomy 0.000 description 2
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 2
- RYYVLZVUVIJVGH-UHFFFAOYSA-N caffeine Chemical compound CN1C(=O)N(C)C(=O)C2=C1N=CN2C RYYVLZVUVIJVGH-UHFFFAOYSA-N 0.000 description 2
- 229910052799 carbon Inorganic materials 0.000 description 2
- 210000004027 cell Anatomy 0.000 description 2
- 238000005119 centrifugation Methods 0.000 description 2
- 238000006243 chemical reaction Methods 0.000 description 2
- 239000008120 corn starch Substances 0.000 description 2
- 229940079593 drug Drugs 0.000 description 2
- 230000007613 environmental effect Effects 0.000 description 2
- 238000002474 experimental method Methods 0.000 description 2
- 239000000706 filtrate Substances 0.000 description 2
- OVBPIULPVIDEAO-LBPRGKRZSA-N folic acid Chemical compound C=1N=C2NC(N)=NC(=O)C2=NC=1CNC1=CC=C(C(=O)N[C@@H](CCC(O)=O)C(O)=O)C=C1 OVBPIULPVIDEAO-LBPRGKRZSA-N 0.000 description 2
- 235000013376 functional food Nutrition 0.000 description 2
- 230000000055 hyoplipidemic effect Effects 0.000 description 2
- 238000011534 incubation Methods 0.000 description 2
- 230000002401 inhibitory effect Effects 0.000 description 2
- 229910052500 inorganic mineral Inorganic materials 0.000 description 2
- 230000037356 lipid metabolism Effects 0.000 description 2
- 230000007774 longterm Effects 0.000 description 2
- 235000004213 low-fat Nutrition 0.000 description 2
- 239000011707 mineral Substances 0.000 description 2
- 238000002156 mixing Methods 0.000 description 2
- 210000000056 organ Anatomy 0.000 description 2
- 229910052700 potassium Inorganic materials 0.000 description 2
- 239000002243 precursor Substances 0.000 description 2
- 230000002265 prevention Effects 0.000 description 2
- 235000018102 proteins Nutrition 0.000 description 2
- 102000004169 proteins and genes Human genes 0.000 description 2
- 108090000623 proteins and genes Proteins 0.000 description 2
- 239000003642 reactive oxygen metabolite Substances 0.000 description 2
- 230000009467 reduction Effects 0.000 description 2
- 238000011160 research Methods 0.000 description 2
- 239000012086 standard solution Substances 0.000 description 2
- 229960001052 streptozocin Drugs 0.000 description 2
- 239000000758 substrate Substances 0.000 description 2
- 239000006228 supernatant Substances 0.000 description 2
- 230000001629 suppression Effects 0.000 description 2
- VZGDMQKNWNREIO-UHFFFAOYSA-N tetrachloromethane Chemical compound ClC(Cl)(Cl)Cl VZGDMQKNWNREIO-UHFFFAOYSA-N 0.000 description 2
- 150000003626 triacylglycerols Chemical class 0.000 description 2
- 229940116269 uric acid Drugs 0.000 description 2
- 235000019155 vitamin A Nutrition 0.000 description 2
- 239000011719 vitamin A Substances 0.000 description 2
- 229940045997 vitamin a Drugs 0.000 description 2
- 229940075420 xanthine Drugs 0.000 description 2
- 239000007218 ym medium Substances 0.000 description 2
- OILXMJHPFNGGTO-UHFFFAOYSA-N (22E)-(24xi)-24-methylcholesta-5,22-dien-3beta-ol Natural products C1C=C2CC(O)CCC2(C)C2C1C1CCC(C(C)C=CC(C)C(C)C)C1(C)CC2 OILXMJHPFNGGTO-UHFFFAOYSA-N 0.000 description 1
- RQOCXCFLRBRBCS-UHFFFAOYSA-N (22E)-cholesta-5,7,22-trien-3beta-ol Natural products C1C(O)CCC2(C)C(CCC3(C(C(C)C=CCC(C)C)CCC33)C)C3=CC=C21 RQOCXCFLRBRBCS-UHFFFAOYSA-N 0.000 description 1
- XUFXOAAUWZOOIT-SXARVLRPSA-N (2R,3R,4R,5S,6R)-5-[[(2R,3R,4R,5S,6R)-5-[[(2R,3R,4S,5S,6R)-3,4-dihydroxy-6-methyl-5-[[(1S,4R,5S,6S)-4,5,6-trihydroxy-3-(hydroxymethyl)-1-cyclohex-2-enyl]amino]-2-oxanyl]oxy]-3,4-dihydroxy-6-(hydroxymethyl)-2-oxanyl]oxy]-6-(hydroxymethyl)oxane-2,3,4-triol Chemical compound O([C@H]1O[C@H](CO)[C@H]([C@@H]([C@H]1O)O)O[C@H]1O[C@@H]([C@H]([C@H](O)[C@H]1O)N[C@@H]1[C@@H]([C@@H](O)[C@H](O)C(CO)=C1)O)C)[C@@H]1[C@@H](CO)O[C@@H](O)[C@H](O)[C@H]1O XUFXOAAUWZOOIT-SXARVLRPSA-N 0.000 description 1
- MZOFCQQQCNRIBI-VMXHOPILSA-N (3s)-4-[[(2s)-1-[[(2s)-1-[[(1s)-1-carboxy-2-hydroxyethyl]amino]-4-methyl-1-oxopentan-2-yl]amino]-5-(diaminomethylideneamino)-1-oxopentan-2-yl]amino]-3-[[2-[[(2s)-2,6-diaminohexanoyl]amino]acetyl]amino]-4-oxobutanoic acid Chemical compound OC[C@@H](C(O)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCN=C(N)N)NC(=O)[C@H](CC(O)=O)NC(=O)CNC(=O)[C@@H](N)CCCCN MZOFCQQQCNRIBI-VMXHOPILSA-N 0.000 description 1
- WJMFXQBNYLYADA-UHFFFAOYSA-N 1-(3,4-dihydroxyphenyl)-6,7-dihydroxy-1,2-dihydronaphthalene-2,3-dicarboxylic acid Chemical compound C12=CC(O)=C(O)C=C2C=C(C(O)=O)C(C(=O)O)C1C1=CC=C(O)C(O)=C1 WJMFXQBNYLYADA-UHFFFAOYSA-N 0.000 description 1
- HMUNWXXNJPVALC-UHFFFAOYSA-N 1-[4-[2-(2,3-dihydro-1H-inden-2-ylamino)pyrimidin-5-yl]piperazin-1-yl]-2-(2,4,6,7-tetrahydrotriazolo[4,5-c]pyridin-5-yl)ethanone Chemical compound C1C(CC2=CC=CC=C12)NC1=NC=C(C=N1)N1CCN(CC1)C(CN1CC2=C(CC1)NN=N2)=O HMUNWXXNJPVALC-UHFFFAOYSA-N 0.000 description 1
- LDXJRKWFNNFDSA-UHFFFAOYSA-N 2-(2,4,6,7-tetrahydrotriazolo[4,5-c]pyridin-5-yl)-1-[4-[2-[[3-(trifluoromethoxy)phenyl]methylamino]pyrimidin-5-yl]piperazin-1-yl]ethanone Chemical compound C1CN(CC2=NNN=C21)CC(=O)N3CCN(CC3)C4=CN=C(N=C4)NCC5=CC(=CC=C5)OC(F)(F)F LDXJRKWFNNFDSA-UHFFFAOYSA-N 0.000 description 1
- YLZOPXRUQYQQID-UHFFFAOYSA-N 3-(2,4,6,7-tetrahydrotriazolo[4,5-c]pyridin-5-yl)-1-[4-[2-[[3-(trifluoromethoxy)phenyl]methylamino]pyrimidin-5-yl]piperazin-1-yl]propan-1-one Chemical compound N1N=NC=2CN(CCC=21)CCC(=O)N1CCN(CC1)C=1C=NC(=NC=1)NCC1=CC(=CC=C1)OC(F)(F)F YLZOPXRUQYQQID-UHFFFAOYSA-N 0.000 description 1
- OQMZNAMGEHIHNN-UHFFFAOYSA-N 7-Dehydrostigmasterol Natural products C1C(O)CCC2(C)C(CCC3(C(C(C)C=CC(CC)C(C)C)CCC33)C)C3=CC=C21 OQMZNAMGEHIHNN-UHFFFAOYSA-N 0.000 description 1
- 206010003210 Arteriosclerosis Diseases 0.000 description 1
- 210000002237 B-cell of pancreatic islet Anatomy 0.000 description 1
- XNCOSPRUTUOJCJ-UHFFFAOYSA-N Biguanide Chemical compound NC(N)=NC(N)=N XNCOSPRUTUOJCJ-UHFFFAOYSA-N 0.000 description 1
- 229940123208 Biguanide Drugs 0.000 description 1
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 1
- 235000006719 Cassia obtusifolia Nutrition 0.000 description 1
- 102000004127 Cytokines Human genes 0.000 description 1
- 108090000695 Cytokines Proteins 0.000 description 1
- AUNGANRZJHBGPY-UHFFFAOYSA-N D-Lyxoflavin Natural products OCC(O)C(O)C(O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-UHFFFAOYSA-N 0.000 description 1
- 239000011665 D-biotin Substances 0.000 description 1
- 235000000638 D-biotin Nutrition 0.000 description 1
- ZZZCUOFIHGPKAK-UHFFFAOYSA-N D-erythro-ascorbic acid Natural products OCC1OC(=O)C(O)=C1O ZZZCUOFIHGPKAK-UHFFFAOYSA-N 0.000 description 1
- 208000002249 Diabetes Complications Diseases 0.000 description 1
- DNVPQKQSNYMLRS-NXVQYWJNSA-N Ergosterol Natural products CC(C)[C@@H](C)C=C[C@H](C)[C@H]1CC[C@H]2C3=CC=C4C[C@@H](O)CC[C@]4(C)[C@@H]3CC[C@]12C DNVPQKQSNYMLRS-NXVQYWJNSA-N 0.000 description 1
- 241000206602 Eukaryota Species 0.000 description 1
- 235000009419 Fagopyrum esculentum Nutrition 0.000 description 1
- 240000008620 Fagopyrum esculentum Species 0.000 description 1
- 102000003638 Glucose-6-Phosphatase Human genes 0.000 description 1
- 108010086800 Glucose-6-Phosphatase Proteins 0.000 description 1
- 229920002527 Glycogen Polymers 0.000 description 1
- 206010019280 Heart failures Diseases 0.000 description 1
- 208000035150 Hypercholesterolemia Diseases 0.000 description 1
- 208000031226 Hyperlipidaemia Diseases 0.000 description 1
- 206010061218 Inflammation Diseases 0.000 description 1
- LPHGQDQBBGAPDZ-UHFFFAOYSA-N Isocaffeine Natural products CN1C(=O)N(C)C(=O)C2=C1N(C)C=N2 LPHGQDQBBGAPDZ-UHFFFAOYSA-N 0.000 description 1
- 206010048469 Kidney enlargement Diseases 0.000 description 1
- 235000015468 Lycium chinense Nutrition 0.000 description 1
- 244000241872 Lycium chinense Species 0.000 description 1
- OVBPIULPVIDEAO-UHFFFAOYSA-N N-Pteroyl-L-glutaminsaeure Natural products C=1N=C2NC(N)=NC(=O)C2=NC=1CNC1=CC=C(C(=O)NC(CCC(O)=O)C(O)=O)C=C1 OVBPIULPVIDEAO-UHFFFAOYSA-N 0.000 description 1
- GXCLVBGFBYZDAG-UHFFFAOYSA-N N-[2-(1H-indol-3-yl)ethyl]-N-methylprop-2-en-1-amine Chemical compound CN(CCC1=CNC2=C1C=CC=C2)CC=C GXCLVBGFBYZDAG-UHFFFAOYSA-N 0.000 description 1
- AFCARXCZXQIEQB-UHFFFAOYSA-N N-[3-oxo-3-(2,4,6,7-tetrahydrotriazolo[4,5-c]pyridin-5-yl)propyl]-2-[[3-(trifluoromethoxy)phenyl]methylamino]pyrimidine-5-carboxamide Chemical compound O=C(CCNC(=O)C=1C=NC(=NC=1)NCC1=CC(=CC=C1)OC(F)(F)F)N1CC2=C(CC1)NN=N2 AFCARXCZXQIEQB-UHFFFAOYSA-N 0.000 description 1
- 206010028980 Neoplasm Diseases 0.000 description 1
- 208000028389 Nerve injury Diseases 0.000 description 1
- 208000012902 Nervous system disease Diseases 0.000 description 1
- 208000025966 Neurological disease Diseases 0.000 description 1
- 208000008589 Obesity Diseases 0.000 description 1
- 201000002451 Overnutrition Diseases 0.000 description 1
- 241000194105 Paenibacillus polymyxa Species 0.000 description 1
- 235000002789 Panax ginseng Nutrition 0.000 description 1
- 244000131316 Panax pseudoginseng Species 0.000 description 1
- 235000005035 Panax pseudoginseng ssp. pseudoginseng Nutrition 0.000 description 1
- 235000003140 Panax quinquefolius Nutrition 0.000 description 1
- 241001556138 Phellinus ribis Species 0.000 description 1
- 102000016611 Proteoglycans Human genes 0.000 description 1
- 108010067787 Proteoglycans Proteins 0.000 description 1
- 208000001647 Renal Insufficiency Diseases 0.000 description 1
- 240000004808 Saccharomyces cerevisiae Species 0.000 description 1
- 229930006000 Sucrose Natural products 0.000 description 1
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 1
- 229940100389 Sulfonylurea Drugs 0.000 description 1
- 108060008682 Tumor Necrosis Factor Proteins 0.000 description 1
- 102000000852 Tumor Necrosis Factor-alpha Human genes 0.000 description 1
- 206010067584 Type 1 diabetes mellitus Diseases 0.000 description 1
- 229910052770 Uranium Inorganic materials 0.000 description 1
- 229930003268 Vitamin C Natural products 0.000 description 1
- QYSXJUFSXHHAJI-XFEUOLMDSA-N Vitamin D3 Natural products C1(/[C@@H]2CC[C@@H]([C@]2(CCC1)C)[C@H](C)CCCC(C)C)=C/C=C1\C[C@@H](O)CCC1=C QYSXJUFSXHHAJI-XFEUOLMDSA-N 0.000 description 1
- 229930003427 Vitamin E Natural products 0.000 description 1
- 229930003448 Vitamin K Natural products 0.000 description 1
- FMRLDPWIRHBCCC-UHFFFAOYSA-L Zinc carbonate Chemical compound [Zn+2].[O-]C([O-])=O FMRLDPWIRHBCCC-UHFFFAOYSA-L 0.000 description 1
- 230000002159 abnormal effect Effects 0.000 description 1
- 229960002632 acarbose Drugs 0.000 description 1
- XUFXOAAUWZOOIT-UHFFFAOYSA-N acarviostatin I01 Natural products OC1C(O)C(NC2C(C(O)C(O)C(CO)=C2)O)C(C)OC1OC(C(C1O)O)C(CO)OC1OC1C(CO)OC(O)C(O)C1O XUFXOAAUWZOOIT-UHFFFAOYSA-N 0.000 description 1
- 238000009825 accumulation Methods 0.000 description 1
- 239000013543 active substance Substances 0.000 description 1
- 230000006978 adaptation Effects 0.000 description 1
- 238000005273 aeration Methods 0.000 description 1
- 239000003513 alkali Substances 0.000 description 1
- OENHQHLEOONYIE-UKMVMLAPSA-N all-trans beta-carotene Natural products CC=1CCCC(C)(C)C=1/C=C/C(/C)=C/C=C/C(/C)=C/C=C/C=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C OENHQHLEOONYIE-UKMVMLAPSA-N 0.000 description 1
- 229940024606 amino acid Drugs 0.000 description 1
- 238000010171 animal model Methods 0.000 description 1
- 230000003712 anti-aging effect Effects 0.000 description 1
- 230000000844 anti-bacterial effect Effects 0.000 description 1
- 208000011775 arteriosclerosis disease Diseases 0.000 description 1
- 230000001363 autoimmune Effects 0.000 description 1
- 235000013734 beta-carotene Nutrition 0.000 description 1
- 239000011648 beta-carotene Substances 0.000 description 1
- TUPZEYHYWIEDIH-WAIFQNFQSA-N beta-carotene Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1=C(C)CCCC1(C)C)C=CC=C(/C)C=CC2=CCCCC2(C)C TUPZEYHYWIEDIH-WAIFQNFQSA-N 0.000 description 1
- 229960002747 betacarotene Drugs 0.000 description 1
- 230000004071 biological effect Effects 0.000 description 1
- 230000036765 blood level Effects 0.000 description 1
- 238000010241 blood sampling Methods 0.000 description 1
- 229960001948 caffeine Drugs 0.000 description 1
- VJEONQKOZGKCAK-UHFFFAOYSA-N caffeine Natural products CN1C(=O)N(C)C(=O)C2=C1C=CN2C VJEONQKOZGKCAK-UHFFFAOYSA-N 0.000 description 1
- FAPWYRCQGJNNSJ-UBKPKTQASA-L calcium D-pantothenic acid Chemical compound [Ca+2].OCC(C)(C)[C@@H](O)C(=O)NCCC([O-])=O.OCC(C)(C)[C@@H](O)C(=O)NCCC([O-])=O FAPWYRCQGJNNSJ-UBKPKTQASA-L 0.000 description 1
- MKJXYGKVIBWPFZ-UHFFFAOYSA-L calcium lactate Chemical compound [Ca+2].CC(O)C([O-])=O.CC(O)C([O-])=O MKJXYGKVIBWPFZ-UHFFFAOYSA-L 0.000 description 1
- 239000001527 calcium lactate Substances 0.000 description 1
- 235000011086 calcium lactate Nutrition 0.000 description 1
- 229960002401 calcium lactate Drugs 0.000 description 1
- 201000011510 cancer Diseases 0.000 description 1
- 230000023852 carbohydrate metabolic process Effects 0.000 description 1
- 235000021256 carbohydrate metabolism Nutrition 0.000 description 1
- 150000001720 carbohydrates Chemical class 0.000 description 1
- 235000014633 carbohydrates Nutrition 0.000 description 1
- 239000005018 casein Substances 0.000 description 1
- BECPQYXYKAMYBN-UHFFFAOYSA-N casein, tech. Chemical compound NCCCCC(C(O)=O)N=C(O)C(CC(O)=O)N=C(O)C(CCC(O)=N)N=C(O)C(CC(C)C)N=C(O)C(CCC(O)=O)N=C(O)C(CC(O)=O)N=C(O)C(CCC(O)=O)N=C(O)C(C(C)O)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=O)N=C(O)C(CCC(O)=O)N=C(O)C(COP(O)(O)=O)N=C(O)C(CCC(O)=N)N=C(O)C(N)CC1=CC=CC=C1 BECPQYXYKAMYBN-UHFFFAOYSA-N 0.000 description 1
- 235000021240 caseins Nutrition 0.000 description 1
- 230000005779 cell damage Effects 0.000 description 1
- 208000037887 cell injury Diseases 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- OIDPCXKPHYRNKH-UHFFFAOYSA-J chrome alum Chemical compound [K]OS(=O)(=O)O[Cr]1OS(=O)(=O)O1 OIDPCXKPHYRNKH-UHFFFAOYSA-J 0.000 description 1
- 239000007979 citrate buffer Substances 0.000 description 1
- FDJOLVPMNUYSCM-UVKKECPRSA-L cobalt(3+);[(2r,3s,4r,5s)-5-(5,6-dimethylbenzimidazol-1-yl)-4-hydroxy-2-(hydroxymethyl)oxolan-3-yl] [(2r)-1-[3-[(2r,3r,4z,7s,9z,12s,13s,14z,17s,18s,19r)-2,13,18-tris(2-amino-2-oxoethyl)-7,12,17-tris(3-amino-3-oxopropyl)-3,5,8,8,13,15,18,19-octamethyl-2,7, Chemical compound [Co+3].N#[C-].C1([C@H](CC(N)=O)[C@@]2(C)CCC(=O)NC[C@@H](C)OP([O-])(=O)O[C@H]3[C@H]([C@H](O[C@@H]3CO)N3C4=CC(C)=C(C)C=C4N=C3)O)[N-]\C2=C(C)/C([C@H](C\2(C)C)CCC(N)=O)=N/C/2=C\C([C@H]([C@@]/2(CC(N)=O)C)CCC(N)=O)=N\C\2=C(C)/C2=N[C@]1(C)[C@@](C)(CC(N)=O)[C@@H]2CCC(N)=O FDJOLVPMNUYSCM-UVKKECPRSA-L 0.000 description 1
- 238000007796 conventional method Methods 0.000 description 1
- 229940116318 copper carbonate Drugs 0.000 description 1
- GEZOTWYUIKXWOA-UHFFFAOYSA-L copper;carbonate Chemical compound [Cu+2].[O-]C([O-])=O GEZOTWYUIKXWOA-UHFFFAOYSA-L 0.000 description 1
- 238000011461 current therapy Methods 0.000 description 1
- 230000001086 cytosolic effect Effects 0.000 description 1
- 230000006378 damage Effects 0.000 description 1
- 230000003412 degenerative effect Effects 0.000 description 1
- 229940111685 dibasic potassium phosphate Drugs 0.000 description 1
- 230000000378 dietary effect Effects 0.000 description 1
- 235000013325 dietary fiber Nutrition 0.000 description 1
- 238000007865 diluting Methods 0.000 description 1
- ZPWVASYFFYYZEW-UHFFFAOYSA-L dipotassium hydrogen phosphate Chemical compound [K+].[K+].OP([O-])([O-])=O ZPWVASYFFYYZEW-UHFFFAOYSA-L 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 230000002554 disease preventive effect Effects 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- BVTBRVFYZUCAKH-UHFFFAOYSA-L disodium selenite Chemical compound [Na+].[Na+].[O-][Se]([O-])=O BVTBRVFYZUCAKH-UHFFFAOYSA-L 0.000 description 1
- 235000006694 eating habits Nutrition 0.000 description 1
- 230000002526 effect on cardiovascular system Effects 0.000 description 1
- 239000012636 effector Substances 0.000 description 1
- DNVPQKQSNYMLRS-SOWFXMKYSA-N ergosterol Chemical compound C1[C@@H](O)CC[C@]2(C)[C@H](CC[C@]3([C@H]([C@H](C)/C=C/[C@@H](C)C(C)C)CC[C@H]33)C)C3=CC=C21 DNVPQKQSNYMLRS-SOWFXMKYSA-N 0.000 description 1
- 238000000855 fermentation Methods 0.000 description 1
- 230000004151 fermentation Effects 0.000 description 1
- 229960002413 ferric citrate Drugs 0.000 description 1
- 229930003935 flavonoid Natural products 0.000 description 1
- 150000002215 flavonoids Chemical class 0.000 description 1
- 235000017173 flavonoids Nutrition 0.000 description 1
- 239000000796 flavoring agent Substances 0.000 description 1
- 235000019634 flavors Nutrition 0.000 description 1
- 229960000304 folic acid Drugs 0.000 description 1
- 235000019152 folic acid Nutrition 0.000 description 1
- 239000011724 folic acid Substances 0.000 description 1
- 235000012631 food intake Nutrition 0.000 description 1
- 230000037406 food intake Effects 0.000 description 1
- WIGCFUFOHFEKBI-UHFFFAOYSA-N gamma-tocopherol Natural products CC(C)CCCC(C)CCCC(C)CCCC1CCC2C(C)C(O)C(C)C(C)C2O1 WIGCFUFOHFEKBI-UHFFFAOYSA-N 0.000 description 1
- 235000008434 ginseng Nutrition 0.000 description 1
- 230000004153 glucose metabolism Effects 0.000 description 1
- 229940096919 glycogen Drugs 0.000 description 1
- 238000000227 grinding Methods 0.000 description 1
- 230000036541 health Effects 0.000 description 1
- 231100000753 hepatic injury Toxicity 0.000 description 1
- 241000411851 herbal medicine Species 0.000 description 1
- 230000000871 hypocholesterolemic effect Effects 0.000 description 1
- 229940126904 hypoglycaemic agent Drugs 0.000 description 1
- 230000001900 immune effect Effects 0.000 description 1
- 230000036737 immune function Effects 0.000 description 1
- 210000000987 immune system Anatomy 0.000 description 1
- 230000036039 immunity Effects 0.000 description 1
- 230000002434 immunopotentiative effect Effects 0.000 description 1
- 208000015181 infectious disease Diseases 0.000 description 1
- 239000007924 injection Substances 0.000 description 1
- 238000002347 injection Methods 0.000 description 1
- 239000002054 inoculum Substances 0.000 description 1
- NPFOYSMITVOQOS-UHFFFAOYSA-K iron(III) citrate Chemical compound [Fe+3].[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O NPFOYSMITVOQOS-UHFFFAOYSA-K 0.000 description 1
- 208000017169 kidney disease Diseases 0.000 description 1
- 201000006370 kidney failure Diseases 0.000 description 1
- 238000002350 laparotomy Methods 0.000 description 1
- 230000004132 lipogenesis Effects 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 210000005228 liver tissue Anatomy 0.000 description 1
- 210000002540 macrophage Anatomy 0.000 description 1
- 239000000395 magnesium oxide Substances 0.000 description 1
- CPLXHLVBOLITMK-UHFFFAOYSA-N magnesium oxide Inorganic materials [Mg]=O CPLXHLVBOLITMK-UHFFFAOYSA-N 0.000 description 1
- AXZKOIWUVFPNLO-UHFFFAOYSA-N magnesium;oxygen(2-) Chemical compound [O-2].[Mg+2] AXZKOIWUVFPNLO-UHFFFAOYSA-N 0.000 description 1
- XMWCXZJXESXBBY-UHFFFAOYSA-L manganese(ii) carbonate Chemical compound [Mn+2].[O-]C([O-])=O XMWCXZJXESXBBY-UHFFFAOYSA-L 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 238000005259 measurement Methods 0.000 description 1
- 230000007246 mechanism Effects 0.000 description 1
- 210000003584 mesangial cell Anatomy 0.000 description 1
- 229910021645 metal ion Inorganic materials 0.000 description 1
- 230000000813 microbial effect Effects 0.000 description 1
- 235000010755 mineral Nutrition 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 230000008764 nerve damage Effects 0.000 description 1
- 230000000926 neurological effect Effects 0.000 description 1
- 230000003472 neutralizing effect Effects 0.000 description 1
- 229960003512 nicotinic acid Drugs 0.000 description 1
- 235000001968 nicotinic acid Nutrition 0.000 description 1
- 239000011664 nicotinic acid Substances 0.000 description 1
- 229910052757 nitrogen Inorganic materials 0.000 description 1
- 102000039446 nucleic acids Human genes 0.000 description 1
- 108020004707 nucleic acids Proteins 0.000 description 1
- 150000007523 nucleic acids Chemical class 0.000 description 1
- 235000020824 obesity Nutrition 0.000 description 1
- 238000012261 overproduction Methods 0.000 description 1
- 230000003647 oxidation Effects 0.000 description 1
- 238000007254 oxidation reaction Methods 0.000 description 1
- SHUZOJHMOBOZST-UHFFFAOYSA-N phylloquinone Natural products CC(C)CCCCC(C)CCC(C)CCCC(=CCC1=C(C)C(=O)c2ccccc2C1=O)C SHUZOJHMOBOZST-UHFFFAOYSA-N 0.000 description 1
- 230000001766 physiological effect Effects 0.000 description 1
- 239000002504 physiological saline solution Substances 0.000 description 1
- 238000011020 pilot scale process Methods 0.000 description 1
- 150000008442 polyphenolic compounds Chemical class 0.000 description 1
- 235000013824 polyphenols Nutrition 0.000 description 1
- OTYBMLCTZGSZBG-UHFFFAOYSA-L potassium sulfate Chemical compound [K+].[K+].[O-]S([O-])(=O)=O OTYBMLCTZGSZBG-UHFFFAOYSA-L 0.000 description 1
- 229910052939 potassium sulfate Inorganic materials 0.000 description 1
- 235000011151 potassium sulphates Nutrition 0.000 description 1
- 230000003449 preventive effect Effects 0.000 description 1
- ZUFQODAHGAHPFQ-UHFFFAOYSA-N pyridoxine hydrochloride Chemical compound Cl.CC1=NC=C(CO)C(CO)=C1O ZUFQODAHGAHPFQ-UHFFFAOYSA-N 0.000 description 1
- 229960004172 pyridoxine hydrochloride Drugs 0.000 description 1
- 235000019171 pyridoxine hydrochloride Nutrition 0.000 description 1
- 239000011764 pyridoxine hydrochloride Substances 0.000 description 1
- 230000000384 rearing effect Effects 0.000 description 1
- 230000002829 reductive effect Effects 0.000 description 1
- 235000019192 riboflavin Nutrition 0.000 description 1
- 229960002477 riboflavin Drugs 0.000 description 1
- 239000002151 riboflavin Substances 0.000 description 1
- 238000005070 sampling Methods 0.000 description 1
- 238000000926 separation method Methods 0.000 description 1
- 239000011780 sodium chloride Substances 0.000 description 1
- 239000011781 sodium selenite Substances 0.000 description 1
- 235000015921 sodium selenite Nutrition 0.000 description 1
- 229960001471 sodium selenite Drugs 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 239000002904 solvent Substances 0.000 description 1
- 150000003431 steroids Chemical class 0.000 description 1
- 238000003756 stirring Methods 0.000 description 1
- 239000005720 sucrose Substances 0.000 description 1
- YROXIXLRRCOBKF-UHFFFAOYSA-N sulfonylurea Chemical compound OC(=N)N=S(=O)=O YROXIXLRRCOBKF-UHFFFAOYSA-N 0.000 description 1
- 208000024891 symptom Diseases 0.000 description 1
- 235000019640 taste Nutrition 0.000 description 1
- 150000003505 terpenes Chemical class 0.000 description 1
- 235000007586 terpenes Nutrition 0.000 description 1
- 230000001225 therapeutic effect Effects 0.000 description 1
- 238000002560 therapeutic procedure Methods 0.000 description 1
- DPJRMOMPQZCRJU-UHFFFAOYSA-M thiamine hydrochloride Chemical compound Cl.[Cl-].CC1=C(CCO)SC=[N+]1CC1=CN=C(C)N=C1N DPJRMOMPQZCRJU-UHFFFAOYSA-M 0.000 description 1
- 231100000331 toxic Toxicity 0.000 description 1
- 230000002588 toxic effect Effects 0.000 description 1
- GXPHKUHSUJUWKP-UHFFFAOYSA-N troglitazone Chemical compound C1CC=2C(C)=C(O)C(C)=C(C)C=2OC1(C)COC(C=C1)=CC=C1CC1SC(=O)NC1=O GXPHKUHSUJUWKP-UHFFFAOYSA-N 0.000 description 1
- 229960001641 troglitazone Drugs 0.000 description 1
- GXPHKUHSUJUWKP-NTKDMRAZSA-N troglitazone Natural products C([C@@]1(OC=2C(C)=C(C(=C(C)C=2CC1)O)C)C)OC(C=C1)=CC=C1C[C@H]1SC(=O)NC1=O GXPHKUHSUJUWKP-NTKDMRAZSA-N 0.000 description 1
- 208000035408 type 1 diabetes mellitus 1 Diseases 0.000 description 1
- 210000000689 upper leg Anatomy 0.000 description 1
- 235000019154 vitamin C Nutrition 0.000 description 1
- 239000011718 vitamin C Substances 0.000 description 1
- QYSXJUFSXHHAJI-YRZJJWOYSA-N vitamin D3 Chemical compound C1(/[C@@H]2CC[C@@H]([C@]2(CCC1)C)[C@H](C)CCCC(C)C)=C\C=C1\C[C@@H](O)CCC1=C QYSXJUFSXHHAJI-YRZJJWOYSA-N 0.000 description 1
- 235000005282 vitamin D3 Nutrition 0.000 description 1
- 239000011647 vitamin D3 Substances 0.000 description 1
- 235000019165 vitamin E Nutrition 0.000 description 1
- 229940046009 vitamin E Drugs 0.000 description 1
- 239000011709 vitamin E Substances 0.000 description 1
- 235000019168 vitamin K Nutrition 0.000 description 1
- 239000011712 vitamin K Substances 0.000 description 1
- 150000003721 vitamin K derivatives Chemical class 0.000 description 1
- 229940045999 vitamin b 12 Drugs 0.000 description 1
- 229940021056 vitamin d3 Drugs 0.000 description 1
- 150000003722 vitamin derivatives Chemical class 0.000 description 1
- 229940046010 vitamin k Drugs 0.000 description 1
- 230000004580 weight loss Effects 0.000 description 1
- 239000011667 zinc carbonate Substances 0.000 description 1
- 235000004416 zinc carbonate Nutrition 0.000 description 1
- 229910000010 zinc carbonate Inorganic materials 0.000 description 1
- OENHQHLEOONYIE-JLTXGRSLSA-N β-Carotene Chemical compound CC=1CCCC(C)(C)C=1\C=C\C(\C)=C\C=C\C(\C)=C\C=C\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C OENHQHLEOONYIE-JLTXGRSLSA-N 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/06—Fungi, e.g. yeasts
- A61K36/07—Basidiomycota, e.g. Cryptococcus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/06—Fungi, e.g. yeasts
- A61K36/062—Ascomycota
- A61K36/064—Saccharomycetales, e.g. baker's yeast
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/75—Rutaceae (Rue family)
- A61K36/752—Citrus, e.g. lime, orange or lemon
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/82—Theaceae (Tea family), e.g. camellia
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
- C12N1/14—Fungi; Culture media therefor
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
- C12P1/00—Preparation of compounds or compositions, not provided for in groups C12P3/00 - C12P39/00, by using microorganisms or enzymes
- C12P1/02—Preparation of compounds or compositions, not provided for in groups C12P3/00 - C12P39/00, by using microorganisms or enzymes by using fungi
Definitions
- the present invention relates to an extract from a submerged culture of Fomitopsis pinicola mycelia in a medium containing an extract from citrus peel or green tea, and a composition for lowering blood sugar levels, comprising the same. More particularly, the present invention relates to an extract from the cultured mycelia of Fomitopsis pinicola, which is superior in hypoglycemic, hypolipidemic and antioxidation activity.
- Diabetes mellitus is generally classified into insulin-dependent type and non insulin-dependent type.
- Cytokines have been implicated as immunological effector molecules that mediate autoimmune destruction of pancreatic beta cells, which is associated with insulin-dependent diabetes mellitus.
- non insulin-dependent diabetes mellitus it is characterized by tissue- wide insulin resistance due to obesity, resulting in the overproduction of TNF- ⁇ and in an increase in macrophage activity.
- Approximately 90% or more of diabetes mellitus in Korea is observed to be non insulin-dependent type 2.
- Patients with diabetes mellitus feature an acute increase in blood glucose level and an abnormality in lipid metabolism.
- diet control is very important in practice. According to diet therapy aiming to normalize glucose and lipid levels in blood, it is recommended to eat low-fat and low-glucose diets to restrain an increase in blood glucose and insulin level.
- Acarbose, a polysaccharide, and dietary fibers are representative of low-fat and low-glucose diets.
- Recent studies have reported that physiologically active substances contained in red ginseng, Chinese matrimony vine, buckwheat, sicklepod(Cassia tora L.), and/or mushrooms have hypoglycemic effects, triggering the onset of active research thereto.
- mushrooms which are eukaryotes, are low in lipid content, but contain ample nutrients, such as proteins, carbohydrates, minerals, nucleic acids and vitamins, and characteristic tastes and flavors.
- the vitamin precursor Ergosterol is highly abundant therein.
- submerged mycelial culture Since submerged mycelial culture has a low growth rate and is apt to be contaminated, it is very important to determine medium ingredients in consideration of abilities to shorten culture periods, produce mycelia of uniform quality on a mass scale, be economically advantageous, easily extract useful materials, and develop mycelia and media as well as biologically active materials into foods. Thus far, submerged mycelial culture has been usually conducted in synthetic media, and although ginseng slices and brewery yeast extract were utilized, natural media have to be studied further.
- One of the most popular methods of extracting polysaccharides from mushroom comprises slicing fruit bodies, adding the slices to distilled water, heating at 85-110°C for 205 hrs, adding ethanol to form a precipitate, and dialyzing the precipitate.
- a fermented solution is concentrated for 24 hrs in an ul- trafilter with a cutoff set at 100,000 and the concentrate is added to two volumes of acetone and left at 4°C for 24 hrs to obtain ex vivo crude polysaccharides from Phellinus ribis.
- polysaccharides can be obtained from Bacillus polymyxa KS-I by diluting a fermented solution with distilled water, adding NaOH to a concentration of l%(w/v) to separate the cells, centrifuging the solution, neutralizing the supernatant, and adding ethanol to form a precipitate.
- Fomitopsis pinicola a Korean autogenous mushroom, is known to contain antibacterial steroids and functional, unknown proteoglycans and has been empirically shown to have antidiabetic effects.
- Korean Pat. Laid-Open Publication No. 2005-60726 discloses a hypoglycemic agent comprising an extract of Fomitopsis pinic ola cultured in a potato medium and a preparation method thereof.
- the present inventors have discovered various pharmaceutical and therapeutic functions of extracts from Fomitopsis pinicola, including the prevention of diabetes complications and diabetes-induced hypercholesterolemia(Korean Pat. Appl'n No. 2006-1430), the suppression of pancreatic cell injury(Korean Pat. Appl'n No.
- Green tea containing free amino acids, caffeine, vitamin C, and polyphenols in small amounts, is known to have various physiological activities, including antioxidation, anticancer activity, anti-inflammation, hypocholes- terolemic action and hypertension prevention. Rich in the vitamin A precursor ⁇ - carotene, flavonoids, and terpenes, citrus peel is known to show effective antioxidation, anti-aging, cardiovascular disease preventive, immunopotentiation, and anticancer activity.
- the present inventors employed extracts from green tea and citrus peel as ingredients of natural media for culturing mycelia of Fomitopsis pinicola, which can overcome the unsanitary problem of synthetic media and which themselves can be utilized as drinks, and succeeded in establishing optimal conditions in the natural media (Korean Pat. Appl'n No. 2005-133989).
- a method for preparing a hot- water extract and an alkali extract from fruit bodies of Fomitopsis pinicola and an extract from cultured mycelia of Fomitopsis pinicola, which all are rich in polysaccharides has been reported (Korean Pat. Appl'n No. 2006-1430).
- It is another object of the present invention to provide a hypoglycemic composition comprising the mycelial culture extract from Fomitopsis pinicola.
- compositions effective for lowering the blood sugar level in especially, patients with a diabetes mellitus, comprising an extract from Fomitopsis pinicola mycelia which is cultured in a natural medium containing green tea or citrus peel.
- the green tea or citrus peel medium used in the present invention can be prepared according to the method disclosed in Korean Pat. Appl'n No. 2005-133989, which is incorporated by reference herein.
- Green tea powder is added to distilled water, and heated for 2-3 hrs in the presence of a cooling tube.
- the filtered solution is mixed in an amount of 2.0%(v/v) to give a green tea medium.
- a citrus peel medium can be prepared by adding distilled water to citrus peel powder, heating it for 2-3 hrs in the presence of a cooling tube, and mixing the filtered solution in an amount of 2.0%(v/v).
- the said hypoglycemic composition showing anti-diabetic effect comprises the extract from a submerged mycelial culture of Fomitopsis pinicola alone, but preferably in combination with a hot- water extract from fruit bodies of Fomitopsis pinicola and optionally further with the culture medium.
- the extracts from submerged cultures of Fomitopsis pinicola in media containing green tea or citrus peel extracts are superior in anti-diabetic activity. With great hypoglycemic activity, the extracts of the present invention find various applications in the functional food industry. Best Mode for Carrying Out the Invention
- the present invention pertains to an anti-diabetic extract from a submerged mycelial culture of Fomitopsis pinicola cultured in a green tea or citrus peel medium.
- the present invention pertains to a hypoglycemic composition
- a hypoglycemic composition comprising the extract from a submerged mycelial culture of Fomitopsis pinicola.
- the hypoglycemic composition comprises the extract from a submerged mycelial culture of Fomitopsis pinicola alone, but preferably in combination with a hot- water extract from fruit bodies of Fomitopsis pinicola and optionally further with the culture medium.
- the green tea or citrus peel medium used in the present invention can be prepared according to the method disclosed in Korean Pat. Appl'n No. 2005-133989, which is incorporated by reference herein.
- Green tea powder is added to distilled water, and heated for 2-3 hrs in the presence of a cooling tube.
- the filtered solution is mixed in an amount of 2.0%(v/v) to give a green tea medium.
- a citrus peel medium can be prepared by adding distilled water to citrus peel powder, heating it for 2-3 hrs in the presence of a cooling tube, and mixing the filtered solution in an amount of 2.0%(v/v).
- the hot- water extract from fruit bodies of Fomitopsis pinicola it can be obtained by finely powdering the fruit bodies, adding distilled water to the powder, and heating the solution for 24 hrs in an extraction bath equipped with a cooling tube to give a concentrate.
- a potato medium is used to obtain an extract from cultured mycelia of Fomitopsis pinicola.
- the mycelia is inoculated in a YM medium and sub-cultured.
- a sterile potato medium potato hot-water extract 10 ⁇ 20%(v/v), sugar l ⁇ 3%(w/v), corn starch powder 0.1 ⁇ 0.5%(w/v) and edible water 76.5 ⁇ 88.9%(v/v)
- the extract can be obtained by concentrating the culture medium(Korean Pat. Publication No. 2005-60726).
- EXAMPLE 1 Culturing of Mycelia of Fomitopsis pinicola in Green Tea Medium and Citrus Peel Medium
- Mycelia were separated from fruit bodies of 1 -year-old Fomitopsis pinicola, purchased from Jeseng Farm, located in Pohang City, Korea. The fruit bodies were cut to a size of 2x2x2mm, washed with 70%(v/v) ethanol and transferred in an amount of 5.0%(w/v) to a medium containing potato 2.0%(w/v), sugar 1.0%(w/v) and peptone 0.6%(w/v), followed by incubation for 10 days with shaking at 150rpm.
- the mycelia were inoculated on a YM agar plate(yeast extract 0.5%(w/v), peptone 0.5%(w/v), malt extract 0.2%(w/v), glucose 1.0%(v/v), and agar 2.0%(w/v), pH 6.5) and incubated at 30°C for 5-6 days before sub-culturing every 15 days.
- a green tea extract was prepared with hot water as described above. Green tea, purchased from Amore Pacific, Korea, was pulverized and filtered through a 100 mesh sieve. To lOOg of the green tea powder was added 2.5L of distilled water which was then heated for 2 hrs in an extraction bath equipped with a cooling tube. The solution was filtered through Miracloth (BioChem Co. U.S.A.) and the filtrate was used as a green tea extract in the present invention.
- Citrus peel purchased from an herbal medicine market in Daegu, Korea, dried, pulverized, and passed through a 100 mesh sieve. To lOOg of the citrus peel powder was added 2.5L of distilled water which was then heated for 2 hrs in an extraction bath equipped with a cooling tube. The solution was filtered through Miracloth(BioChem Co. U.S.A.) and the filtrate was used as a citrus peel extract in the present invention.
- the green tea extract was mixed with necessary ingredients to prepare a green tea medium(the green tea extract 2%(v/v), glucose 5%(v/v), yeast extract 0.5%(w/v), peptone 0.5%(w/v) and malt extract 0.3%(w/v), pH 5.0).
- a citrus peel medium was prepared using the citrus peel extract 2%(v/v) instead of the green tea extract 2%(v/v).
- the mycelia of Fomitopsis pinicola obtained in Example 1 - 1 , were inoculated in the green tea medium and the citrus peel medium, and incubated at 30°C for 12 days with shaking at 150rpm. After being neutralized to pH 7.0 with NaHCO , the cultures were homogenized and concentrated at 40°C to 1/20 of their initial volume. These concentrates were used as extracts from the cultured mycelia of Fomitopsis pinicola.
- DM-PD diabetes mellitus-induced group administered with 2% of the concentrate(l/20) from a submerged culture of Fomitopsis pinicola in the potato(PD) medium
- DM-CP diabetes mellitus-induced group administered with 2% of the concentrate(l/20) from a submerged culture of Fomitopsis pinicola in the citrus peel(CP) medium
- DM-GT diabetes mellitus-induced group administered with 2% of the concentrate(l/20) from a submerged culture of Fomitopsis pinicola in the green tea(GT) medium
- DM-WE diabetes mellitus-induced group administered with 2% of hot-water extract(WE) from fruit bodies of Fomitopsis pinicola
- DM-WC diabetes mellitus-induced group administered with 2% of a mixture of
- EXAMPLE 3-2 Anti-Diabetic Activity
- weight loss was measured to be 17% for the DM-GT group, 16% for the DM-CP group, 32% for the DM-PD group, 23% for the DM-WE group and 15% for the DM-WC group, with about two-fold greater effect of the submerged cultures in the green tea medium, the citrus peel medium, or a mixture of fruit hot- water extract and citrus peel medium than those in the conventional potato medium.
- the strongest effects on dietary intake, FER, water intake and urine output were detected in the DM-CP group and the DM-WC group(see: Table 2).
- ⁇ NC normal control
- DM diabetes mellitus control
- DM-PD 2% of the concentrate(l/20) from the submerged culture in the potato(PD) medium was administered after the induction of diabetes mellitus
- DM-CP 2% of the concentrate(l/20) from the submerged culture in the citrus peel(CP) medium was administered after the induction of diabetes mellitus
- DM-GT 2% of the concentrate(l/20) from the submerged culture in the green tea(GT) medium was administered after the induction of diabetes mellitus
- DM-WE 2% of hot-water extract(WE) from fruit bodies was administered after the induction of diabetes mellitus
- DM-WC 2% of a mixture of 1 : 1 the hot-water extract from fruit bodies : the concentrate from the submerged culture in the citrus peel medium was administered after the induction of diabetes mellitus
- Organ Weight When afflicted with diabetes mellitus, cells fail to conduct normal glucose metabolism due to low insulin levels and high insulin resistance while lipogenesis occurs with the aid of acetyl-CoA, resulting in the accumulation of lipids in the liver. Particularly, rats in which diabetes mellitus was induced with STZ were found to increase the activity of hepatic glucose-6-phosphatase, involved in carbohydrate metabolism, resulting in liver enlargement. Kidney enlargement was also found because when increased in level due to diabetes mellitus, plasma glucose is metabolized into glycogen which is accumulated in mesangial cells of the aglomerulus.
- EXAMPLE 4 Suppressive Effect of Fomitopsis pinicola Extract on Diabetes Mellitus-Induced Hyperlipidemia and on Hepatic Xanthine Oxidase Activity
- Example 3 The same experimental groups and diets as in Example 3 were conducted. After being fed with the experimental diets for 4 weeks, the animals were starved for 24 hrs with only water fed thereto. They were etherized and subjected to laparotomy along the ventral median line to expose the ventral aorta, from which blood was then sampled and analyzed for sugar level. The liver was perfused with iced physiological saline and excised. The sampled blood was left at a cold temperature for 7 hrs, followed by cen- trifugation at 3,000 rpm for 10 min to separate sera.
- the excised liver was immersed in 4 volumes of a 0.25M sucrose solution and homogenized on ice, followed by cen- trifugation at 10,000x g for 30 min.
- the cytosolic fraction obtained as the supernatant was stored, along with other samples, in a deep freezer maintained at -70°C.
- mg/dL (Absorbance of standard solution/Absorbance of test sample) x 100.
- 0.1 ml of the serum was reacted with 3.0 ml of the enzyme solution at 37°C for 5 min and absorbance at 500nm was measured.
- Blood LDL-cholesterol level could be calculated according to Total Cholesterol level - (HDL-Cholesterol level) - (Triglyceride level/5).
- the blood triglyceride level increased remarkably, by about 73%, in the DM group, but slightly, by 16% in the DM-GT group, by 8% in the DM-CP group, and by 7% in the DM-WC group, and moderately, by 47% in the DM- PD group and by 39% by the DM-WE group.
- the DM-WC group and the DM-CP group both comparable, were lowest in level increase.
- the HDL-cholesterol level of the DM group was 19% lower than that of the NC group, but there was no significant difference in HDL-cholesterol level between the experimental groups fed with the extracts and the NC group.
- the DM group was 42% higher in LDL-cholesterol level. In this level, however, the DM-WC group, the DM-CP group and the DM-GT group were comparable to or lower than the NC group.
- the extracts from the submerged cultures in the media according to the present invention were found to decrease blood lipid levels efficiently compared to the extract from the submerged culture in the conventional potato medium, (see Table 5).
- Hepatic xanthine oxidase activity was determined according to the method of Strirpe in which xanthine is used as a substrate for reaction at 30°C for 10 min to produce uric acid and absorbance at 292nm is measured. The activity of the enzyme was expressed as the concentration(nmol) of the uric acid produced as a result of the reaction of lmg of the liver tissue protein with the substrate for 1 min.
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Chemical & Material Sciences (AREA)
- Mycology (AREA)
- Engineering & Computer Science (AREA)
- Biotechnology (AREA)
- General Health & Medical Sciences (AREA)
- Microbiology (AREA)
- Organic Chemistry (AREA)
- Botany (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- Wood Science & Technology (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Medical Informatics (AREA)
- Veterinary Medicine (AREA)
- Zoology (AREA)
- Epidemiology (AREA)
- Alternative & Traditional Medicine (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Genetics & Genomics (AREA)
- Biochemistry (AREA)
- General Engineering & Computer Science (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Tropical Medicine & Parasitology (AREA)
- Virology (AREA)
- Biomedical Technology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
Disclosed herein are an extract from a submerged culture of Fomitopsis pinicola in a citrus peel medium or a green tea medium, and an anti-diabetic composition comprising the same. With great suppressive effects on blood glucose level, the extract can be applied to various foods for patients with diabetes mellitus.
Description
Description
EXTRACT FROM SUBMERGED CULTURE OF FOMITOPSIS PINICOLA MYCELIA AND HYPOGLYCEMIC COMPOSITION
COMPRISING THE SAME
Technical Field
[1] The present invention relates to an extract from a submerged culture of Fomitopsis pinicola mycelia in a medium containing an extract from citrus peel or green tea, and a composition for lowering blood sugar levels, comprising the same. More particularly, the present invention relates to an extract from the cultured mycelia of Fomitopsis pinicola, which is superior in hypoglycemic, hypolipidemic and antioxidation activity. Background Art
[2] With rapid changes in dietary habits and hypernutrition, attributable to economic growth, degenerative adult diseases, such as cancer, strokes, hypertension, diabetes, etc., are occurring at an increasing rate. In particular, the rate of incidence of diabetes in Korea has drastically increased, amounting to about 3% of the total population, and in particular to about 6.5% of adults 65 years old or older. Diabetes mellitus, although the accurate mechanism remains unclear to date, is known to be treatable with medicaments and diet for one's entire life because it causes a reduction in the body's ability to utilize glucose, and the excess of blood sugar incurs various abnormal immune functions and complications, which lead to cardiovascular, neurological and renal diseases.
[3] Diabetes mellitus is generally classified into insulin-dependent type and non insulin-dependent type. Cytokines have been implicated as immunological effector molecules that mediate autoimmune destruction of pancreatic beta cells, which is associated with insulin-dependent diabetes mellitus. As for non insulin-dependent diabetes mellitus, it is characterized by tissue- wide insulin resistance due to obesity, resulting in the overproduction of TNF-α and in an increase in macrophage activity. Approximately 90% or more of diabetes mellitus in Korea is observed to be non insulin-dependent type 2. Patients with diabetes mellitus feature an acute increase in blood glucose level and an abnormality in lipid metabolism. Aside from acute glucose level abnormalities, the main risks to the health of patients with non insulin-dependent diabetes mellitus are the characteristic long-term complications. These include arteriosclerosis, cardiovascular diseases, nerve damage, and renal failure, leading to death. This is believed to be attributed to a serious change which is brought about in lipid metabolism to increase levels of triglyceride, total cholesterol, and LDL cholesterol and decrease the level of HDL in the blood.
[4] As mentioned above, current therapies for diabetes mellitus rely on a combination of drugs and diet. Long term administration of drugs, such as sulfonyl urea, biguanide and troglitazone, is reported to have negative effects on the human immune system with a high risk of concomitant side effects. Thus, diet control is very important in practice. According to diet therapy aiming to normalize glucose and lipid levels in blood, it is recommended to eat low-fat and low-glucose diets to restrain an increase in blood glucose and insulin level. Acarbose, a polysaccharide, and dietary fibers are representative of low-fat and low-glucose diets. Recent studies have reported that physiologically active substances contained in red ginseng, Chinese matrimony vine, buckwheat, sicklepod(Cassia tora L.), and/or mushrooms have hypoglycemic effects, triggering the onset of active research thereto. Generally, mushrooms, which are eukaryotes, are low in lipid content, but contain ample nutrients, such as proteins, carbohydrates, minerals, nucleic acids and vitamins, and characteristic tastes and flavors. Particularly, the vitamin precursor Ergosterol is highly abundant therein.
[5] From mushrooms, reportedly, materials responsible for various biological activities including anticancer activity, immunity enhancement, hypocholestemic and hypoglycemic action, preventive and curative effects on stroke and heart failure, infection resistance, etc., can be obtained. Almost all of the biologically active materials are found to be polysaccharides, of which, for example, β-l,3-glucan from Lentinus edodes and PS-K extracted from cultured mycelia of Coriolus versicolor are representative.
[6] In studies of mushrooms, nutrient analysis, artificial culture, and polysaccharide extraction have usually been adopted as main themes. As for artificial culture, it is reported to utilize a solid method or a liquid method. The former is low in yield because of requirement for extensive labor and high expense while the latter, although having high yield, needs intrastructural techniques. Lee et al. suggested optimal conditions for culturing mycelia of Lentinus edodes, including a temperature of 25°C, a pH of 4.0, a stirring speed of 300rpm, an inoculum amount of 10%, an aeration rate of 1.0 v/v/m (Lee, B. W., et al., 'Cultural characteristics and pilot scale fermentation for the submerged mycelial culture of Lentinus edodes' Kor. J. Appl. Microbial Biotechnol., 21, 609-614, (1993)). Fraser reported yeast extract and casein as very effective nutrients for culturing mycelia of Agaricus bisporus (Fraser, LM. 'The growth promptive effect of several amino acids on the common cultivated mushroom' Mushroom ScL, 3, 190-200, (1956)). Aside from carbon and nitrogen sources, the growth of mycelia is also highly influenced by other environmental factors including vitamins and metal ions.
[7] Since submerged mycelial culture has a low growth rate and is apt to be contaminated, it is very important to determine medium ingredients in consideration of
abilities to shorten culture periods, produce mycelia of uniform quality on a mass scale, be economically advantageous, easily extract useful materials, and develop mycelia and media as well as biologically active materials into foods. Thus far, submerged mycelial culture has been usually conducted in synthetic media, and although ginseng slices and brewery yeast extract were utilized, natural media have to be studied further.
[8] One of the most popular methods of extracting polysaccharides from mushroom comprises slicing fruit bodies, adding the slices to distilled water, heating at 85-110°C for 205 hrs, adding ethanol to form a precipitate, and dialyzing the precipitate. In another extraction method, a fermented solution is concentrated for 24 hrs in an ul- trafilter with a cutoff set at 100,000 and the concentrate is added to two volumes of acetone and left at 4°C for 24 hrs to obtain ex vivo crude polysaccharides from Phellinus ribis. It is known that polysaccharides can be obtained from Bacillus polymyxa KS-I by diluting a fermented solution with distilled water, adding NaOH to a concentration of l%(w/v) to separate the cells, centrifuging the solution, neutralizing the supernatant, and adding ethanol to form a precipitate. Lee, et al. extracted polysaccharides from Coriolus versicolor using various solvents including hot water(97°C), cold water(4°C), methanol(70°C), ethanol(70°C), acetone(50°C), hexane(50°C), 0.1N NaOH(60°C), and 0.1N HC1(6O°C), reaching the conclusion that polysaccharides can be obtained at a high yield from 10.4 to 18.4% when using hot water, cold water, 0.1N HCl and 0.1N NaOH.
[9] Fomitopsis pinicola, a Korean autogenous mushroom, is known to contain antibacterial steroids and functional, unknown proteoglycans and has been empirically shown to have antidiabetic effects. Korean Pat. Laid-Open Publication No. 2005-60726 discloses a hypoglycemic agent comprising an extract of Fomitopsis pinic ola cultured in a potato medium and a preparation method thereof. Recently, the present inventors have discovered various pharmaceutical and therapeutic functions of extracts from Fomitopsis pinicola, including the prevention of diabetes complications and diabetes-induced hypercholesterolemia(Korean Pat. Appl'n No. 2006-1430), the suppression of pancreatic cell injury(Korean Pat. Appl'n No. 2006-1431), and the suppression of diabetes-induced reactive oxygen species(Korean Pat. Appl'n No. 2005-133990). In our previous studies, the principle which brings about these inhibitory effects was also analyzed to be β- l,3-glucano-β-l,6-heterogalactomannan-protein complex, ranging in molecular weight from 300,000 to 500,000, in which β-l,3-glucan is linked to β- 1 ,6-heterogalactomannan.
[10] However, conventional methods are insufficient to culture Fomitopsis pinicola because synthetic media produce problems of being unsanitary and decreasing in
production yield. Now, available natural media are under extensive study.
[11] The present inventors pay attention to green tea and citrus peel as ingredients of compositions for use in natural media. Green tea, containing free amino acids, caffeine, vitamin C, and polyphenols in small amounts, is known to have various physiological activities, including antioxidation, anticancer activity, anti-inflammation, hypocholes- terolemic action and hypertension prevention. Rich in the vitamin A precursor β- carotene, flavonoids, and terpenes, citrus peel is known to show effective antioxidation, anti-aging, cardiovascular disease preventive, immunopotentiation, and anticancer activity.
[12] The present inventors employed extracts from green tea and citrus peel as ingredients of natural media for culturing mycelia of Fomitopsis pinicola, which can overcome the unsanitary problem of synthetic media and which themselves can be utilized as drinks, and succeeded in establishing optimal conditions in the natural media (Korean Pat. Appl'n No. 2005-133989). In addition, a method for preparing a hot- water extract and an alkali extract from fruit bodies of Fomitopsis pinicola and an extract from cultured mycelia of Fomitopsis pinicola, which all are rich in polysaccharides, has been reported (Korean Pat. Appl'n No. 2006-1430).
[13] Therefore, extracts from fruit bodies of Fomitopsis pinicola, from submerged cultures in natural media, and from submerged cultures in synthetic media and their preparation methods have to be studied further to elicit the best hypoglycemic effects therefrom.
Disclosure of Invention Technical Problem
[14] Leading to the present invention, intensive and thorough research into culture conditions for obtaining biologically active materials of Fomitopsis pinicola and their applications, conducted by the present inventors, resulted in the finding that when Fomitopsis pinicola is cultured in a natural medium containing green tea or citrus peel, an extract from the mycelia thereof exhibits highly useful anti-diabetic effects.
[15] It is therefore an object of the present invention to provide an extract from the cultured mycelia of Fomitopsis pinicola, cultured in a green tea or citrus peel medium, which shows highly anti-diabetic activity.
[16] It is another object of the present invention to provide a hypoglycemic composition comprising the mycelial culture extract from Fomitopsis pinicola.
[17]
Technical Solution
[18] In order to accomplish the above objects, there is provided a composition, effective for lowering the blood sugar level in especially, patients with a diabetes mellitus,
comprising an extract from Fomitopsis pinicola mycelia which is cultured in a natural medium containing green tea or citrus peel.
[19] The green tea or citrus peel medium used in the present invention can be prepared according to the method disclosed in Korean Pat. Appl'n No. 2005-133989, which is incorporated by reference herein. Green tea powder is added to distilled water, and heated for 2-3 hrs in the presence of a cooling tube. The filtered solution is mixed in an amount of 2.0%(v/v) to give a green tea medium. Likewise, a citrus peel medium can be prepared by adding distilled water to citrus peel powder, heating it for 2-3 hrs in the presence of a cooling tube, and mixing the filtered solution in an amount of 2.0%(v/v).
[20] The said hypoglycemic composition showing anti-diabetic effect comprises the extract from a submerged mycelial culture of Fomitopsis pinicola alone, but preferably in combination with a hot- water extract from fruit bodies of Fomitopsis pinicola and optionally further with the culture medium.
Advantageous Effects
[21] the extracts from submerged cultures of Fomitopsis pinicola in media containing green tea or citrus peel extracts are superior in anti-diabetic activity. With great hypoglycemic activity, the extracts of the present invention find various applications in the functional food industry. Best Mode for Carrying Out the Invention
[22] In accordance with an aspect, the present invention pertains to an anti-diabetic extract from a submerged mycelial culture of Fomitopsis pinicola cultured in a green tea or citrus peel medium.
[23] In accordance with another aspect, the present invention pertains to a hypoglycemic composition comprising the extract from a submerged mycelial culture of Fomitopsis pinicola.
[24] The hypoglycemic composition comprises the extract from a submerged mycelial culture of Fomitopsis pinicola alone, but preferably in combination with a hot- water extract from fruit bodies of Fomitopsis pinicola and optionally further with the culture medium.
[25] The green tea or citrus peel medium used in the present invention can be prepared according to the method disclosed in Korean Pat. Appl'n No. 2005-133989, which is incorporated by reference herein. Green tea powder is added to distilled water, and heated for 2-3 hrs in the presence of a cooling tube. The filtered solution is mixed in an amount of 2.0%(v/v) to give a green tea medium. Likewise, a citrus peel medium can be prepared by adding distilled water to citrus peel powder, heating it for 2-3 hrs in the presence of a cooling tube, and mixing the filtered solution in an amount of 2.0%(v/v).
[26] As for the hot- water extract from fruit bodies of Fomitopsis pinicola, it can be
obtained by finely powdering the fruit bodies, adding distilled water to the powder, and heating the solution for 24 hrs in an extraction bath equipped with a cooling tube to give a concentrate.
[27] A potato medium is used to obtain an extract from cultured mycelia of Fomitopsis pinicola. First, the mycelia is inoculated in a YM medium and sub-cultured. Then, it is again inoculated in a sterile potato medium (potato hot-water extract 10~20%(v/v), sugar l~3%(w/v), corn starch powder 0.1~0.5%(w/v) and edible water 76.5~88.9%(v/v)) and cultured. The extract can be obtained by concentrating the culture medium(Korean Pat. Publication No. 2005-60726).
[28] These extracts from Fomitopsis pinicola were assayed for hypoglycemic and hypolipidemic activity as follows. First, feedstuff containing the extracts was fed for 4 weeks to rats in which diabetes mellitus had been induced with STZ(streptozotocin). Blood samples were taken from the tail vein of each rat to analyze blood sugar levels and from the ventral aorta to analyze blood lipid levels. In addition, each rat was sacrificed to excise the liver and kidneys. The weights of these organs were compared between the rats and the activity of xanthine oxidase in the liver was measured.
[29] A better understanding of the present invention may be obtained in light of the following examples, which are set forth to illustrate, but are not to be construed to limit the present invention. Mode for the Invention
[30] EXAMPLES
[31]
[32] EXAMPLE 1 : Culturing of Mycelia of Fomitopsis pinicola in Green Tea Medium and Citrus Peel Medium
[33]
[34] EXAMPLE 1 - 1 : Separation of Mycelia of Fomitopsis pinicola
[35]
[36] Mycelia were separated from fruit bodies of 1 -year-old Fomitopsis pinicola, purchased from Jeseng Farm, located in Pohang City, Korea. The fruit bodies were cut to a size of 2x2x2mm, washed with 70%(v/v) ethanol and transferred in an amount of 5.0%(w/v) to a medium containing potato 2.0%(w/v), sugar 1.0%(w/v) and peptone 0.6%(w/v), followed by incubation for 10 days with shaking at 150rpm. The mycelia were inoculated on a YM agar plate(yeast extract 0.5%(w/v), peptone 0.5%(w/v), malt extract 0.2%(w/v), glucose 1.0%(v/v), and agar 2.0%(w/v), pH 6.5) and incubated at 30°C for 5-6 days before sub-culturing every 15 days.
[37]
[38] EXAMPLE 1-2: Preparation of Green Tea Medium and Citrus Peel Medium and
Extract from Submerged Culture of Fomitopsis pinicola Therein
[39]
[40] A green tea extract was prepared with hot water as described above. Green tea, purchased from AmorePacific, Korea, was pulverized and filtered through a 100 mesh sieve. To lOOg of the green tea powder was added 2.5L of distilled water which was then heated for 2 hrs in an extraction bath equipped with a cooling tube. The solution was filtered through Miracloth (BioChem Co. U.S.A.) and the filtrate was used as a green tea extract in the present invention. Citrus peel, purchased from an herbal medicine market in Daegu, Korea, dried, pulverized, and passed through a 100 mesh sieve. To lOOg of the citrus peel powder was added 2.5L of distilled water which was then heated for 2 hrs in an extraction bath equipped with a cooling tube. The solution was filtered through Miracloth(BioChem Co. U.S.A.) and the filtrate was used as a citrus peel extract in the present invention.
[41] The green tea extract was mixed with necessary ingredients to prepare a green tea medium(the green tea extract 2%(v/v), glucose 5%(v/v), yeast extract 0.5%(w/v), peptone 0.5%(w/v) and malt extract 0.3%(w/v), pH 5.0). Likewise, a citrus peel medium was prepared using the citrus peel extract 2%(v/v) instead of the green tea extract 2%(v/v).
[42] The mycelia of Fomitopsis pinicola, obtained in Example 1 - 1 , were inoculated in the green tea medium and the citrus peel medium, and incubated at 30°C for 12 days with shaking at 150rpm. After being neutralized to pH 7.0 with NaHCO , the cultures were homogenized and concentrated at 40°C to 1/20 of their initial volume. These concentrates were used as extracts from the cultured mycelia of Fomitopsis pinicola.
[43]
[44] EXAMPLE 2: Hot- Water Extract from Fruit Body of Fomitopsis pinicola and
Mycelial Extract from Submerged Culture of Fomitopsis pinicola
[45]
[46] EXAMPLE 2-1 : Preparation of Hot- Water Extract from Fruit Body of Fomitopsis pinicola
[47]
[48] Fruit bodies of 1 -year-old Fomitopsis pinicola, purchased from Jeseng Farm, located in Pohang City, Korea, were cut to a size of 2x2x2mm and added to 4L of distilled water, followed by extraction for 24 hrs in a bath equipped with a cooling tube. The extract was concentrated to 1/4 of the initial volume to give a solution(3.75g/100mL).
[49]
[50] EXAMPLE 2-2: Preparation of Extract from Submerged Culture in Potato Medium
[51]
[52] Mycelia of Fomitopsis pinicola, purchased from Jeseng Farm, located in Pohang
City, Korea, were inoculated in a YM medium(glucose l%(v/v), yeast extract 0.5%(w/v), peptone 0.5%(w/v) and malt yeast 0.3%(w/v), pH 6.5) and subcultured at 30°C for 10 days. This culture was inoculated in an amount of 5%(v/v) in a potato medium[(potato hot-water extract 15%(v/v), as a dry mass 4%(w/v)), sugar 2%(w/v), corn starch 0.3%(w/v), pH 6.5], which had been sterilized at 121°C for 1 hr and cooled, followed by incubation at 30°C for 12 days with shaking at 150rpm. After being neutralized to pH 7.0 with NaHCO , the culture was homogenized and concentrated at 40°C to 1/20 of its initial volume.
[53]
[54] EXAMPLE 3: Anti-Diabetic Effects of Extracts from Fomitopsis pinicola
[55]
[56] EXAMPLE 3-1 : Experimental Animals and Method
[57]
[58] SD male rats, each having body weight of 225+5.2g, were divided into 7 groups of
10. For environmental adaptation, they were pre-reared at 23+2°C and RH 60+5% for one week with general feedstuff(Purina Co., Seoul, Korea) in a 12:12 hr light-dark cycle before being fed the experimental diet.
[59] The seven groups are indicated using the following abbreviations.
[60] 1) NC: normal control group
[61] 2) DM: diabetes mellitus control group
[62] 3) DM-PD: diabetes mellitus-induced group administered with 2% of the concentrate(l/20) from a submerged culture of Fomitopsis pinicola in the potato(PD) medium
[63] 4) DM-CP: diabetes mellitus-induced group administered with 2% of the concentrate(l/20) from a submerged culture of Fomitopsis pinicola in the citrus peel(CP) medium
[64] 5) DM-GT: diabetes mellitus-induced group administered with 2% of the concentrate(l/20) from a submerged culture of Fomitopsis pinicola in the green tea(GT) medium
[65] 6) DM-WE: diabetes mellitus-induced group administered with 2% of hot-water extract(WE) from fruit bodies of Fomitopsis pinicola
[66] 7) DM-WC: diabetes mellitus-induced group administered with 2% of a mixture of
1 : 1 the hot- water extract from fruit bodies : the concentrate from a submerged culture in the citrus peel medium
[67] Table 1
[68] AIN-mineral mix(g/kg): Calcium lactate 620.0, sodium chloride 74.0, dibasic potassium phosphate 220.0, potassium sulfate 52.0, magnesium oxide 23.0, manganous carbonate 3.3, ferric citrate 6.0, zinc carbonate 1.0, copper carbonate 0.2, potassium iodide 0.01, sodium selenite 0.01 and potassium chromium sulfate 0.5 were mixed to form a total weight of l,000g and finely powdered.
[69] AIN- vitamin mix(mg/kg): thiamin hydrochloride 600, riboflavin 600, pyridoxine hydrochloride 700, nicotinic acid 3,000, calcium D-pantothenate 1,600, folic acid 200, D-biotin 20, vitamin B 12 2.5, vitamin A 400,000 IU, vitamin D3 100,000 IU, vitamin E 7,500 IU and vitamin K 75 were mixed to form a total weight of 1,000 g and finely powdered.
[70] [71] EXAMPLE 3-2: Anti-Diabetic Activity
[72] [73] Weight Gain. Dietary Intake and Food Efficiency [74] [75] A solution of streptozotocin(STZ, Sigma Chem. Co. MO, U.S. A.) in 0.1 M citrate buffer(pH 4.3) was injected in a dose of 40mg/kg into the thigh. Animals which had a blood sugar level of 300 mg/dL, measured with a blood sample taken from the tail vein 48 hrs after injection with STZ, were regarded as having diabetes mellitus induced therein.
[76] Blood sugar levels were measured using Gluco-Tester(Life Scan Inc., U.S.A.) at 10-12 a.m. Blood sampling was performed with lancet from the tail vein of rats which had been starved until the sampling time.
[77] Over the experiment period, body weight, dietary intake, and water intake were measured at a predetermined time each day, and the food efficiency ratio(FER) was defined as the ratio of weight gain to dietary intake in the same time period. The weight gain, dietary intake, and FER are given in Table 2, below.
[78] The DM group remarkably lost weight(58% decreased) but increased 14% in dietary intake, 84% in water intake and 108% in urine output compared with the NC group. Likewise, the other groups showed an increase in the three aspects and a decrease in weight gain. However, these symptoms were largely alleviated, demonstrating the anti-diabetic activity of the extracts. High anti-diabetic effects, far superior to those obtained in the conventional potato medium, were observed particularly in the DM-WC group and the DM-GT group. In detail, weight loss was measured to be 17% for the DM-GT group, 16% for the DM-CP group, 32% for the DM-PD group, 23% for the DM-WE group and 15% for the DM-WC group, with about two-fold greater effect of the submerged cultures in the green tea medium, the citrus peel medium, or a mixture of fruit hot- water extract and citrus peel medium than those in the conventional potato medium. The strongest effects on dietary intake, FER, water intake and urine output were detected in the DM-CP group and the DM-WC group(see: Table 2).
[79] Table 2
Effect of 4- Week Administration with Fomitopsis pinicola Extracts on Weight Gain, Food Intake, Food Efficiency Ratio and Urine Output of Diabetes Mellitus-Induced Rats
[80] ^NC: normal control, DM: diabetes mellitus control, DM-PD: 2% of the concentrate(l/20) from the submerged culture in the potato(PD) medium was administered after the induction of diabetes mellitus, DM-CP: 2% of the concentrate(l/20) from the submerged culture in the citrus peel(CP) medium was administered after the induction of diabetes mellitus, DM-GT: 2% of the concentrate(l/20) from the submerged culture in the green tea(GT) medium was administered after the induction of diabetes mellitus, DM-WE: 2% of hot-water extract(WE) from fruit bodies was administered after the induction of diabetes mellitus, DM-WC: 2% of a mixture of 1 : 1 the hot-water extract from fruit bodies : the concentrate from the submerged culture in the citrus peel medium was administered after the induction of diabetes mellitus
[81] food efficiency ratio: weight gain/dietary intake [82]
[83] Organ Weight [84] [85] When afflicted with diabetes mellitus, cells fail to conduct normal glucose metabolism due to low insulin levels and high insulin resistance while lipogenesis occurs with the aid of acetyl-CoA, resulting in the accumulation of lipids in the liver. Particularly, rats in which diabetes mellitus was induced with STZ were found to increase the activity of hepatic glucose-6-phosphatase, involved in carbohydrate
metabolism, resulting in liver enlargement. Kidney enlargement was also found because when increased in level due to diabetes mellitus, plasma glucose is metabolized into glycogen which is accumulated in mesangial cells of the aglomerulus.
[86] During rearing for 4 weeks after the induction of diabetes mellitus, the rats were monitored for weight of the liver and kidneys. The DM group was measured to increase 48% in liver weight compared to the NC group as expressed as a weight% on the basis of body weight. Thus, liver enlargement was caused by diabetes mellitus. The livers of the experimental groups fed with the extracts of the present invention were smaller than those of the DM group. The largest alleviation effects were measured in the DM-CP group and the DM-WC group. The same phenomena were found for the kidneys(see: Table 3).
[87] Table 3
Effect of 4- Week Administration with Fomitopsis pinicola Extracts on Liver and Kidney Weights (% of Body Weight)
[88] the same as in Table 2 [89] Avg.+SD obtained from 10 rats of each group, different letters indicating a significance within 5%.
[90] [91] Blood Glucose [92] [93] While being fed for 4 weeks with the experimental diets, the diabetes mellitus- induced rats were monitored for blood glucose level. The DM group maintained a blood glucose level from 523.5 to 546.5 mg/dL for the period. Lower blood glucose levels were measured in the groups fed with the extracts of the present invention. In Week 4, the blood glucose level was reduced by 69% in the DM-GT group, 74% in the DM-CP group, 53% in the DM-PD group, 58% in the DM-WE group, and 75% in the DM-WC group. Depending on the culture condition of the mycelia, the blood glucose
reduction efficiency varied. Better effects were shown when using concentrates obtained from cultures in the citrus peel medium or the green tea medium or using mixtures of hot- water extract therewith than when using the concentrates obtained from cultures in the conventional potato medium(see: Table 4). After the extract from the submerged culture in the conventional potato medium was fed for 4 weeks, the blood glucose level was decreased by about 292 mg/dl, which corresponded to a rate of about 53%. On the other hand, the difference of blood glucose level between pre- and post-administration of the extract from the submerged culture in the citrus peel medium amounted to about 406 mg/dl, which corresponded to a decrease of about 74%.
[94] Table 4
Blood Glucose Levels of Diabetes Mellitus-Induced Rats During Administration with Fomitopsis pinicola Extract
[95] ''the same as in Table 2 [96] Avg.+SD obtained from 10 rats of each group, different letters showing a significance within 5%.
[97] [98] EXAMPLE 4: Suppressive Effect of Fomitopsis pinicola Extract on Diabetes Mellitus-Induced Hyperlipidemia and on Hepatic Xanthine Oxidase Activity
[99] [100] The same experimental groups and diets as in Example 3 were conducted. After being fed with the experimental diets for 4 weeks, the animals were starved for 24 hrs with only water fed thereto. They were etherized and subjected to laparotomy along the ventral median line to expose the ventral aorta, from which blood was then sampled and analyzed for sugar level. The liver was perfused with iced physiological saline and excised. The sampled blood was left at a cold temperature for 7 hrs, followed by cen-
trifugation at 3,000 rpm for 10 min to separate sera. The excised liver was immersed in 4 volumes of a 0.25M sucrose solution and homogenized on ice, followed by cen- trifugation at 10,000x g for 30 min. The cytosolic fraction obtained as the supernatant was stored, along with other samples, in a deep freezer maintained at -70°C.
[101]
[102] Analysis of serum lipid level
[103] For the measurement of blood levels of triglycerides, total cholesterol and HDL cholesterol, commercially available kits were used(AM 157S-K, AM 202-K, AM 203-K, Asanpharm Co., Korea). The triglyceride level was determined by measuring absorbance at 550 nm after 0.02 ml of the serum was mixed and reacted at 37°C for 10 min with 3.0 ml of the enzyme solution. To determine the total cholesterol level according to the formula mg/dL = (Absorbance of standard solution/Absorbance of test sample) x 300, the serum was reacted with the enzyme solution, as in triglycerides at 37°C, but for 5 min, and absorbance at 500 nm was obtained. As for the HLD- cholesterol value, it was calculated according to the following formula mg/dL = (Absorbance of standard solution/Absorbance of test sample) x 100. In this regard, 0.1 ml of the serum was reacted with 3.0 ml of the enzyme solution at 37°C for 5 min and absorbance at 500nm was measured. Blood LDL-cholesterol level could be calculated according to Total Cholesterol level - (HDL-Cholesterol level) - (Triglyceride level/5).
[104] Compared to the NC group, the blood triglyceride level increased remarkably, by about 73%, in the DM group, but slightly, by 16% in the DM-GT group, by 8% in the DM-CP group, and by 7% in the DM-WC group, and moderately, by 47% in the DM- PD group and by 39% by the DM-WE group. As seen, the DM-WC group and the DM-CP group, both comparable, were lowest in level increase.
[105] The total cholesterol level showed the same tendency as in the triglyceride level, with no significance.
[106] The HDL-cholesterol level of the DM group was 19% lower than that of the NC group, but there was no significant difference in HDL-cholesterol level between the experimental groups fed with the extracts and the NC group.
[107] Compared to the NC group, the DM group was 42% higher in LDL-cholesterol level. In this level, however, the DM-WC group, the DM-CP group and the DM-GT group were comparable to or lower than the NC group. Thus, the extracts from the submerged cultures in the media according to the present invention were found to decrease blood lipid levels efficiently compared to the extract from the submerged culture in the conventional potato medium, (see Table 5).
[108] Table 5
[109] ''the same as in Table 2. [HO] 2)Total cholesterol-(HDL-Cholesterol+Triglyceride/5). [111] 3)Avg.+SD obtained from 10 rats of each group, different letters (a-c)showing a significance within 5%.
[112] [113] Hepatic xanthine oxidase activity [114] [115] Hepatic xanthine oxidase(XOD) activity was determined according to the method of Strirpe in which xanthine is used as a substrate for reaction at 30°C for 10 min to produce uric acid and absorbance at 292nm is measured. The activity of the enzyme was expressed as the concentration(nmol) of the uric acid produced as a result of the reaction of lmg of the liver tissue protein with the substrate for 1 min.
[116] Upon hepatic injury, XOD activity increases. The administration of toxic materials, such as ethanol, carbon tetrachloride, STZ, etc., causes XOD activity to increase to promote the oxidation of xanthine. Higher O type activity and O/T ratios(%) indicate the generation of more reactive oxygen species.
[117] After being fed for 4 weeks with the experimental feeds, the diabetes mellitus-induc ed rats were analyzed for XOD activity and the results are given in Table 6, below. As seen in Table 6, there is no significant difference in XOD activity among them, but the O type activity and O/T(%) of the DM-CP group, the DM-WC group and the DM-GT group were remarkably low compared to that of the DM-PD group, and comparable to that of the NC group, implying that the extract from the submerged cultures in the media according to the present invention has great inhibitory activity against the generation of ROS.
[118] Table 6 Hepatic XOD Activity of Diabetes Mellitus-Induced Rats After Administration with
Experimental Diets for 4 Weeks
[119] 1)rrhe same as in Table 2. [120] Avg.+SD obtained from 10 rats of each group, different letters (a-c)showing a significance within 5%.
[121]
Industrial Applicability [122] As described hitherto, the extracts from submerged cultures of Fomitopsis pinicola in media containing green tea or citrus peel extracts are superior in anti-diabetic activity. With great hypoglycemic activity, the extracts of the present invention find various applications in the functional food industry.
[123] [124] The present invention has been described in an illustrative manner, and it is to be understood that the terminology used is intended to be in the nature of description rather than of limitation. Many modifications and variations of the present invention are possible in light of the above teachings. Therefore, it is to be understood that within the scope of the appended claims, the invention may be practiced otherwise than as specifically described.
[125]
Claims
[1] An extract from a submerged culture of Fomitopsis pinicola cultured in a green tea medium or a citrus peel medium.
[2] The extract according to claim 1, wherein the green tea medium comprises
0.5%-3.0%(v/v) of a green tea extract, 3.0%-7.0%(v/v) of glucose, 0.5%-1.5% (w/v) of a yeast extract, 0.1%-1.5%(w/v) of peptone, 0.1%-0.7%(w/v) of a malt extract, and 86.3%-95.8%(v/v) of purified water, said green tea extract being obtained by infusing green tea powder in hot water and filtering the solution.
[3] The extract according to claim 1, wherein the citrus peel medium comprises
0.5%-3.0%(v/v) of a citrus peel extract, 3.0%-7.0%(v/v) of glucose, 0.5%-1.5%(w/v) of a yeast extract, 0.1%-1.5%(w/v) of peptone, 0.1%-0.7%(w/v) of a malt extract, and 86.3%-95.8%(v/v) of purified water, said citrus peel extract being obtained by infusing citrus peel powder in hot water and filtering the solution.
[4] A hypoglycemic composition, comprising the extract of claim 1.
[5] The hypoglycemic composition according to claim 4, further comprising a hot- water extract from fruit bodies of Fomitopsis pinicola.
[6] The hypoglycemic composition according to claim 5, wherein the hot- water extract is obtained by mincing and pulverizing the fruit bodies of Fomitopsis pinicola, immersing the pulverized fruit bodies in distilled water, heating the water for 24 hrs in an extraction bath equipped with a cooling tube, and concentrating the extract collected in the cooling tube.
[7] The hypoglycemic composition according to claim 4, further comprising a filtered, submerged culture of Fomitopsis pinicola in the green tea medium or the citrus peel medium.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR10-2006-0011691 | 2006-02-07 | ||
KR1020060011691 | 2006-02-07 |
Publications (1)
Publication Number | Publication Date |
---|---|
WO2007091827A1 true WO2007091827A1 (en) | 2007-08-16 |
Family
ID=38345384
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/KR2007/000646 WO2007091827A1 (en) | 2006-02-07 | 2007-02-07 | Extract from submerged culture of fomitopsis pinicola mycelia and hypoglycemic composition comprising the same |
Country Status (1)
Country | Link |
---|---|
WO (1) | WO2007091827A1 (en) |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN102835240A (en) * | 2012-09-03 | 2012-12-26 | 苏延友 | Cultivation method of selenium-enriched Codonopsis lanceolata, as well as extraction method and application of selenium-containing polysaccharide of selenium-enriched Codonopsis lanceolata |
CN108220168A (en) * | 2016-12-14 | 2018-06-29 | 康盛时代(北京)生物技术有限公司 | A kind of culture medium and its application |
Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3291701A (en) * | 1962-07-06 | 1966-12-13 | Swift & Co | Beta-carotene production and composition therefor |
JPH01272508A (en) * | 1988-04-22 | 1989-10-31 | Japan Tobacco Inc | Production of controlling agent of plant virus by micro-organism |
JPH07116A (en) * | 1991-06-03 | 1995-01-06 | Mayumi Horitsu | Food and drink of coffee |
KR20050060726A (en) * | 2003-12-17 | 2005-06-22 | 김천환 | Hypoglycemics including fomitosis pinicola extraction and preparing method thereof |
KR20060008341A (en) * | 2006-01-09 | 2006-01-26 | 조은희 | The fast method of culture on mycellia of phellinus linteus in grain media which coating green tea leaf |
-
2007
- 2007-02-07 WO PCT/KR2007/000646 patent/WO2007091827A1/en active Application Filing
Patent Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3291701A (en) * | 1962-07-06 | 1966-12-13 | Swift & Co | Beta-carotene production and composition therefor |
JPH01272508A (en) * | 1988-04-22 | 1989-10-31 | Japan Tobacco Inc | Production of controlling agent of plant virus by micro-organism |
JPH07116A (en) * | 1991-06-03 | 1995-01-06 | Mayumi Horitsu | Food and drink of coffee |
KR20050060726A (en) * | 2003-12-17 | 2005-06-22 | 김천환 | Hypoglycemics including fomitosis pinicola extraction and preparing method thereof |
KR20060008341A (en) * | 2006-01-09 | 2006-01-26 | 조은희 | The fast method of culture on mycellia of phellinus linteus in grain media which coating green tea leaf |
Non-Patent Citations (2)
Title |
---|
DATABASE WPI Week 198949, Derwent World Patents Index; AN 1989-361681, XP003016627 * |
DATABASE WPI Week 200670, Derwent World Patents Index; AN 2006-677191, XP003016628 * |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN102835240A (en) * | 2012-09-03 | 2012-12-26 | 苏延友 | Cultivation method of selenium-enriched Codonopsis lanceolata, as well as extraction method and application of selenium-containing polysaccharide of selenium-enriched Codonopsis lanceolata |
CN108220168A (en) * | 2016-12-14 | 2018-06-29 | 康盛时代(北京)生物技术有限公司 | A kind of culture medium and its application |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Buswell et al. | Edible mushrooms: attributes and applications | |
Yang et al. | Hypoglycemic effect of a Lentinus edodes exo-polymer producedfrom a submerged mycelial culture | |
CN102994305B (en) | Method for preparing health-care food (therapy) product (nutrient juice wine) by use of extracts from cordyceps militaris and cocoon | |
Yang et al. | Hypoglycemic effects of Ganoderma applanatum and Collybia confluens exo‐polymers in streptozotocin‐induced diabetic rats | |
KR100787633B1 (en) | Tea and Tea Manufacturing Method for Improving Liver Function and Curing of Hangover | |
Oluba et al. | Evaluation of the hypoglycemic effect of aqueous extract of Ganoderma lucidum on STZ-induced diabetic wistar rats | |
CN102498935B (en) | Method for preparing flammulina velutipes nutrient solution by utilizing remains of food processing | |
JP4587442B2 (en) | Novel antihyperlipidemic agent and food | |
CN101664180B (en) | Health-care nutritional complexing agent with health effect and preparation method thereof | |
Lo et al. | Submerged culture mycelium and broth of Grifola frondosa improve glycemic responses in diabetic rats | |
Chen et al. | Subchronic toxicity and genotoxicity studies of Hericium erinaceus β-glucan extract preparation | |
Dilworth et al. | The effect of phytic acid on the levels of blood glucose and some enzymes of carbohydrate and lipid metabolism | |
WO2007091827A1 (en) | Extract from submerged culture of fomitopsis pinicola mycelia and hypoglycemic composition comprising the same | |
KR20180042936A (en) | a composition comprising the mycelium culture medium from Schizophyllum commune as an active ingredient for preventing or treating liver disease and alleviating hangover | |
CN105535035A (en) | Inonotus obliquus fermentation culture composition and preparation method thereof | |
CN102987405B (en) | Method for preparing health food capsules by using cordyceps militaris and cocoon extracts | |
CN102987501B (en) | Method for preparing nutrient (liquid) beverages and granules of healthcare food (therapy) products by using extractives of cordyceps militaris and cocoons | |
JP5684989B2 (en) | Enzyme-treated and gonococcal fermentation-treated product | |
WO2009057954A2 (en) | Composition for improvement of fatty liver | |
KR102296748B1 (en) | Composition for improving, treating or preventing obesity comprising glutinous rice fermented by lactic bacteria as an active ingredient | |
US6465218B1 (en) | Biologically active substance and process of preparing the same | |
KR101228554B1 (en) | The Fermentation Forming Method of Citrus Sunki And The Product thereof | |
KR100859984B1 (en) | Submerged-Liquid Culture Extract of Fomitopsis pinicola Mycelium and Composition Comprising the Same for Lowering Blood Sugar | |
Cha et al. | Effect of Fomitopsis pinicola extract on blood glucose and lipid metabolism in diabetic rats | |
KR20200016610A (en) | Composition for Improvement of Fatty Liver |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
121 | Ep: the epo has been informed by wipo that ep was designated in this application | ||
NENP | Non-entry into the national phase |
Ref country code: DE |
|
122 | Ep: pct application non-entry in european phase |
Ref document number: 07708796 Country of ref document: EP Kind code of ref document: A1 |